Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Diagnosis of Myeloproliferative Neoplasia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02546284
What this trial is testing

Study of Lenzilumab in Previously Treated Patients With Chronic Myelomonocytic Leukemia (CMML)

Who this might be right for
Chronic Myelomonocytic Leukemia (CMML)
Humanigen, Inc. 15
Not applicableStudy completedNCT01611298
What this trial is testing

Donor-Derived Humoral Immunity, Hematopoietic Stem Cell Transplantation, TAR

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myelogenous LeukemiaChronic Myelogenous Leukemia+3 more
Robert Krance 7
Testing effectiveness (Phase 2)Ended earlyNCT03576547
What this trial is testing

Venetoclax, Ponatinib, and Dexamethasone in Participants With Philadelphia Chromosome or BCR-ABL Positive Relapsed or Refractory Acute Lymphoblastic Leukemia or Chronic Myelogenous Leukemia

Who this might be right for
Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositivePhiladelphia Chromosome PositiveRecurrent Acute Lymphoblastic Leukemia+4 more
M.D. Anderson Cancer Center 9
Testing effectiveness (Phase 2)Study completedNCT00005942
What this trial is testing

Liposomal Daunorubicin and SU5416 in Treating Patients With Hematologic Cancer That Has Not Responded to Initial Therapy

Who this might be right for
Chronic Myelomonocytic LeukemiaPreviously Treated Myelodysplastic SyndromesRecurrent Adult Acute Myeloid Leukemia+2 more
National Cancer Institute (NCI) 37
Early research (Phase 1)Study completedNCT02996773
What this trial is testing

Haploidentical BMT With Post-Transplant Cyclophosphamide and Bendamustine

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myelogenous LeukemiaMyelodysplastic Syndromes+10 more
University of Arizona 50
Early research (Phase 1)Study completedNCT00003294
What this trial is testing

Chemotherapy Given With Amifostine and Filgrastim in Treating Patients With Recurrent or Metastatic Cancer

Who this might be right for
LeukemiaLymphomaUnspecified Adult Solid Tumor, Protocol Specific
Roswell Park Cancer Institute 24
Testing effectiveness (Phase 2)Study completedNCT02743351
What this trial is testing

Study of ProTmune for Allogeneic HCT in Adult Patients With Hematologic Malignancies

Who this might be right for
Hematologic MalignanciesAcute Myeloid LeukemiaAcute Lymphoblastic Leukemia+3 more
Fate Therapeutics 96
Early research (Phase 1)Study completedNCT00268229
What this trial is testing

Imatinib Mesylate, Daunorubicin, and Cytarabine in Treating Patients With Relapsed Acute Myeloid Leukemia

Who this might be right for
Leukemia
The Cleveland Clinic 21
Testing effectiveness (Phase 2)Ended earlyNCT01500161
What this trial is testing

Pooled Unrelated Donor Umbilical Cord Blood Transplant For Hematologic Malignancy Needing Allogeneic Stem Cell Transplant Without Related HLA-Match

Who this might be right for
Acute Myelogenous LeukemiaAcute Lymphocytic LeukemiaChronic Lymphocytic Leukemia+6 more
Texas Oncology Cancer Center 1
Testing effectiveness (Phase 2)Looking for participantsNCT06815003
What this trial is testing

Vedolizumab Plus Post-transplant Cyclophosphamide and Short Course Tacrolimus for the Prevention of Graft Versus Host Disease in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation After Reduced Intensity Conditioning

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaChronic Myelomonocytic Leukemia+3 more
City of Hope Medical Center 35
Not applicableWithdrawnNCT00038870
What this trial is testing

Therapy of Relapsed AML With Chemotherapy and Dendritic Cell Activated Lymphocytes

Who this might be right for
Acute Myelogenous LeukemiaChronic Myelogenous Leukemia
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00006251
What this trial is testing

Fludarabine Phosphate, Low-Dose Total-Body Irradiation, and Donor Stem Cell Transplant Followed by Cyclosporine, Mycophenolate Mofetil, Donor Lymphocyte Infusion in Treating Patients With Hematopoietic Cancer

Who this might be right for
Acute Undifferentiated LeukemiaAdult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell Lymphoma+61 more
Fred Hutchinson Cancer Center 21
Early research (Phase 1)Study completedNCT03814005
What this trial is testing

Pevonedistat in People With Blood Cancers or Solid Tumors With Kidney or Liver Problems

Who this might be right for
Myelodysplastic SyndromesLeukemia, Myelomonocytic, ChronicLeukemia, Myeloid, Acute+3 more
Takeda 17
Not applicableUnknownNCT05566535
What this trial is testing

Changes in QoL and Symptoms in Patients With Polycythemia Vera Receiving Ruxo in a Routine Clinical Practice

Who this might be right for
Polycythemia Vera
Multinational Center for Quality of Life Research, Russia 32
Large-scale testing (Phase 3)Study completedNCT00481247
What this trial is testing

A Phase III Study of Dasatinib vs Imatinib in Patients With Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia

Who this might be right for
Myeloid Leukemia, Chronic
Bristol-Myers Squibb 547
Early research (Phase 1)Study completedNCT01834248
What this trial is testing

DEC-205/NY-ESO-1 Fusion Protein CDX-1401and Decitabine in Treating Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid LeukemiaAlkylating Agent-Related Acute Myeloid LeukemiaChronic Myelomonocytic Leukemia+2 more
Roswell Park Cancer Institute 9
Not applicableStudy completedNCT04539678
What this trial is testing

SYTHROM Cohort, Myeloproliferative Neoplasia With Normal CBC and Thrombotic Complications

Who this might be right for
Thrombotic PatientsDiagnosis of Myeloproliferative NeoplasiaImpact of Treatment With Cytoreducing Agent
Nantes University Hospital 253
Not applicableLooking for participantsNCT07445438
What this trial is testing

Feasibility of a Multi-omics Platform for Hematological Malignancies

Who this might be right for
Myeloma MultipleChronic LeukemiaAcute Leukemia+3 more
Azienda Ospedaliero-Universitaria di Parma 1,040
Large-scale testing (Phase 3)Not Yet RecruitingNCT07489755
What this trial is testing

TGRX-678 Chinese Phase III in Chronic Myelogenous Leukemia (CML) Patients

Who this might be right for
Chronic Myelogenous LeukemiaChronic Myelogenous Leukemia - Chronic Phase
Shenzhen TargetRx Co., Ltd. 180
Not applicableStudy completedNCT07839858
What this trial is testing

Real-world Use and Effectiveness of Cytoreductive Strategies for the Treatment of Second-line Polycythemia Vera in France

Who this might be right for
Polycythemia Vera
Novartis Pharmaceuticals 237
Next Page